Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

18.3K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-181a post-transcriptionally targets GRK2 to limit maladaptive signaling in cardiomyocytes.

Frontiers in cardiovascular medicine·2026
Same author

Linking phospholipid metabolism to septic cardiomyopathy via HIF-1α overactivation.

Nature cardiovascular research·2025
Same author

Cardiac-Targeted AAV5-S100A1 Gene Therapy Protects Against Adverse Remodeling and Contractile Dysfunction in Postischemic Hearts.

Circulation. Heart failure·2025
Same author

Therapeutic Efficacy of a Novel Pharmacologic GRK2 Inhibitor in Multiple Animal Models of Heart Failure.

JACC. Basic to translational science·2025
Same author

Quantification of Sarcoplasmic Reticulum Ca<sup>2+</sup> Release in Primary Ventricular Cardiomyocytes.

Current protocols·2024
Same author

Podoplanin Positive Cell-derived Extracellular Vesicles Contribute to Cardiac Amyloidosis After Myocardial Infarction.

bioRxiv : the preprint server for biology·2024

Related Experiment Video

Updated: Mar 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Cys340Ser Mutation Abolishing S-Nitrosylation Drives GRK2 Mitochondrial Localization and Dysfunction.

Gizem Kayki Mutlu1, Stephanie M Kereliuk2, Maya Hoteit2

  • 1Department of Pharmacology, Faculty of Pharmacy, Ankara University, Tandogan, 06100 Ankara, Turkey.

Cells
|March 14, 2026
PubMed
Summary

S-nitrosylation normally limits G protein-coupled receptor kinase 2 (GRK2) in mitochondria. Inhibiting this modification worsens cardiac mitochondrial function and dynamics, highlighting GRK2 regulation as a therapeutic target.

Keywords:
GRK2S-nitrosylationhypoxia/reoxygenationmitochondria

More Related Videos

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.5K
Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
05:48

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

3.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.5K
Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein
05:48

Removal of an Internal Translational Start Site from mRNA While Retaining Expression of the Full-Length Protein

Published on: March 16, 2022

3.1K

Area of Science:

  • Cardiovascular Biology
  • Mitochondrial Medicine
  • Molecular Cardiology

Background:

  • G protein-coupled receptor kinase 2 (GRK2) is upregulated in cardiac pathologies.
  • GRK2 contributes to cardiac dysfunction through both receptor-mediated and mitochondrial effects.
  • S-nitrosylation of GRK2 at Cysteine 340 acts as an endogenous brake on its activity.

Purpose of the Study:

  • To investigate the role of S-nitrosylation in regulating GRK2's mitochondrial localization and function.
  • To examine GRK2's impact on mitochondrial dynamics and mitophagy under hypoxia/reoxygenation stress.

Main Methods:

  • Utilized AC16 cardiac cells infected with adenoviruses expressing a GRK2 C340S mutation to block S-nitrosylation.
  • Assessed mitochondrial function via oxygen consumption rates and ATP production.
  • Analyzed mitochondrial dynamics and mitophagy.

Main Results:

  • Inhibition of S-nitrosylation significantly enhanced GRK2's mitochondrial localization, particularly under pathological conditions.
  • Mitochondrial function, including oxygen consumption and ATP production, was impaired when S-nitrosylation was blocked.
  • GRK2 without S-nitrosylation led to adverse outcomes due to altered mitochondrial dynamics and mitophagy.

Conclusions:

  • S-nitrosylation is crucial for regulating GRK2's mitochondrial function and localization in cardiac cells.
  • Disrupting GRK2 S-nitrosylation exacerbates mitochondrial dysfunction and adverse cardiac outcomes.
  • Targeting GRK2 post-translational modifications, like S-nitrosylation, presents a potential therapeutic strategy for cardiac pathologies.